Search Results 91-100 of 13641 for monoclonal antibody
Rituximab is a monoclonal antibody that may interfere with the ability of cancer cells to grow and spread. ... Monoclonal antibodies, such as obinutuzumab, may ...
Mosunetuzumab is a monoclonal antibody that may interfere with the ability of cancer cells to grow and spread. ... antibodies and the factors that may ...
Inotuzumab ozogamicin is a monoclonal antibody, called inotuzumab, linked to a type of chemotherapy called calicheamicin. Inotuzumab attaches to cancer ...
... monoclonal antibody;; The relative lack of awareness by patients and providers of the availability of such therapeutic options; and; The fact that such use of ...
Brentuximab vedotin is a combining monoclonal antibody with an anticancer drug that binds to a protein on the surface of lymphoma cells called cluster of ...
... Monoclonal Antibody Screening Score. Mayo Clin Proc Innov Qual Outcomes. 2023 Apr; 7 (2):109-121 Epub 2023 Jan 11. View PubMed; Yang J, Shin KM, Do A, Bierle ...
Clinical outcome trials study the use of human monoclonal antibodies to target biochemical pathways that impact LDL receptor availability and monoclonal ...
Monoclonal antibodies, such as nivolumab, may interfere with the ability of ... No history of severe hypersensitivity to a monoclonal antibody. Signed ...
Monoclonal antibodies, such as inotuzumab ozogamicin, may block cancer growth in different ways by targeting certain cells. Drugs used in chemotherapy work ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Your donation powers the future of medicine and helps save lives.